Published in Pharmatherapeutica on January 01, 1987
Neurophysiologic evidence for a central sensitization in patients with fibromyalgia. Arthritis Rheum (2003) 2.51
Electroacupuncture in fibromyalgia: results of a controlled trial. BMJ (1992) 2.18
Time of appearance and distribution of cells capable of secondary immune response following primary immunization. Immunology (1967) 1.84
Inorganic pyrophosphate in plasma, urine, and synovial fluid of patients with pyrophosphate arthropathy (chondrocalcinosis or pseudogout). Lancet (1970) 1.77
[Lesions of the brachial plexus occurring after radiotherapy for cancer of the breast]. Schweiz Med Wochenschr (1971) 1.66
Stimulation of mouse B lymphocytes by trypsin. J Immunol (1974) 1.59
The immunological significance in the guinea-pig of in vitro transformation of lymph node, spleen and peripheral blood lymphocytes. Immunology (1968) 1.52
Corticosteroid therapy for the treatment of acute attacks of crystal-induced arthritis: an effective alternative to nonsteroidal antiinflammatory drugs. Rev Rhum Engl Ed (1996) 1.47
Australia antigen and autoantibodies in chronic hepatitis. Br Med J (1970) 1.40
Immunoglobulin-like surface molecules and theta antigen during the specific and non-specific stimulation of mouse spleen cells in vitro. Clin Exp Immunol (1972) 1.38
Lymphocyte cultures in drug hypersensitivity. Lancet (1966) 1.37
Effect of hydrocortisone on the reactivity of thymus and spleen cells of mice to in vitro stimulation. Immunology (1972) 1.36
Amplification of plasmid and chromosome Chlamydia DNA in synovial fluid of patients with reactive arthritis and undifferentiated seronegative oligoarthropathies. Arthritis Rheum (1995) 1.21
In vitro stimulation of lymphocytes by neutral proteinases from human polymorphonuclear leukocyte granules. J Exp Med (1976) 1.21
Chlamydial serology: comparative diagnostic value of immunoblotting, microimmunofluorescence test, and immunoassays using different recombinant proteins as antigens. J Clin Microbiol (2001) 1.19
Rheumatoid arthritis and ankylosing spondylitis occurring together. Br Med J (1976) 1.18
Fibromyalgia: a randomised, controlled trial of a treatment programme based on self management. Ann Rheum Dis (2004) 1.14
Tendon calcifications in chondrocalcinosis. A clinical, radiologic, histologic, and crystallographic study. Arthritis Rheum (1977) 1.13
Cell surface antigen CD5 is a marker for activated human B cells. Eur J Immunol (1989) 1.12
Detection of parvovirus in a patient with "reactive arthritis" by in situ hybridization. Clin Rheumatol (1989) 1.06
Destructive arthropathy in generalized osteoarthritis with articular chondrocalcinosis. J Rheumatol (1975) 1.03
Termination of acquired tolerance by administration of small lymphocytes. J Immunol (1967) 1.01
Sternocostoclavicular hyperostosis: case report with a 31-year followup. Arthritis Rheum (1983) 1.01
Comparative study of different enzyme immunoassays for measurement of IgM and IgA rheumatoid factors. Ann Rheum Dis (2002) 0.99
Effect of antibodies against immunoglobulins and the theta antigen on the specific and non-specific stimulation of mouse spleen cells in vitro. Immunology (1972) 0.98
Two cases of hepatitis due to Toxoplasma gondii. Lancet (1967) 0.96
The painful heel. Comparative study in rheumatoid arthritis, ankylosing spondylitis, Reiter's syndrome, and generalized osteoarthrosis. Ann Rheum Dis (1977) 0.96
Development of immunological memory during the primary immune response. Nature (1967) 0.95
Mitogenic factors produced by lymphocyte activation: effect on T- and B-cells. J Immunol (1972) 0.95
Joint destruction and chondrocalcinosis in patients with generalised osteoarthrosis. Br Med J (1975) 0.94
Is chronic non-specific low back pain chronic? Definitions of a problem and problems of a definition. Br J Gen Pract (1999) 0.93
The differential effect of cholera toxin on the lymphocyte stimulation induced by various mitogens. Immunology (1975) 0.93
Chlamydia trachomatis antibody detection and diagnosis of reactive arthritis. Br J Rheumatol (1998) 0.92
[Synoviorthesis of finger joints using erbium-169. Parameters influencing the clinical results at middle-term]. Schweiz Med Wochenschr (1977) 0.92
The value of isotype determination of serum antibodies against Chlamydia for the diagnosis of Chlamydia reactive arthritis. Br J Rheumatol (1996) 0.91
Activation of macrophages to produce neutral proteinases by endocytosis of alpha 2-macroglobulin-trypsin complexes. J Reticuloendothel Soc (1980) 0.91
Erosive spondylopathy. Ann Rheum Dis (1980) 0.90
Algodystrophy of the knee. Anatomo-radiological study of a case. Clin Rheumatol (1983) 0.89
Health care providers should use a common language in relation to low back pain patients. Baillieres Clin Rheumatol (1998) 0.89
Synovial fluid and serum antibodies against Chlamydia in different forms of arthritis: intra-articular IgA production in Chlamydia sexually acquired reactive arthritis. Br J Rheumatol (1996) 0.89
[Treatment of lumbar sciatica with or without neurological deficit using mechanical traction. A double-blind study]. Schweiz Med Wochenschr (1988) 0.88
Stimulating effect of neutral proteases on cells in vitro. Agents Actions (1976) 0.88
Trypsin increases in vitro antibody synthesis and substitutes for helper T cells. J Immunol (1976) 0.88
Culture of mouse lymphoid cells in serum-free medium. J Immunol Methods (1972) 0.88
An extended HLA-DQ-DR haplotype rather than DRB1 alone contributes to RA predisposition. Immunogenetics (1998) 0.87
The role of congruence between patient and therapist in chronic low back pain patients. J Manipulative Physiol Ther (1996) 0.87
A six year prospective study of a cohort of patients with fibromyalgia. Ann Rheum Dis (2002) 0.86
Chlamydia trachomatis serology: diagnostic value of outer membrane protein 2 compared with that of other antigens. J Clin Microbiol (2001) 0.86
Reactive and undifferentiated arthritis in North Africa: use of PCR for detection of Chlamydia trachomatis. Clin Rheumatol (2008) 0.85
Levamisole and agranulocytosis. Lancet (1977) 0.85
A randomized, double-blind trial comparing a pulse of 1000 with 250 mg methylprednisolone in rheumatoid arthritis. Clin Rheumatol (1986) 0.84
A double-blind study of erbium169 synoviorthesis in rheumatoid digital joints. Results after one year. Scand J Rheumatol (1979) 0.83
The differential effect of cyclic AMP on lymphocyte stimulation by T- or B-cell mitogens. Immunology (1976) 0.83
Importance of species-specific antigens in the serodiagnosis of Chlamydia trachomatis reactive arthritis. Rheumatology (Oxford) (2002) 0.83
In vitro stimulation of lymphocytes by neutral proteinases from human polymorphonuclear leukocyte granules. Schweiz Med Wochenschr (1976) 0.83
Evaluation of commercially available tests for Chlamydia nucleic acid detection in synovial fluid of patients. Br J Rheumatol (1997) 0.81
The role of prior knowledge on back-pain education. J Spinal Disord (1992) 0.81
The gap between back pain patients' prior knowledge and scientific knowledge and its evolution after a back school teaching programme: a quantitative evaluation. Patient Educ Couns (1996) 0.81
[Therapeutic results of osmic acid synovio-orthesis]. Schweiz Med Wochenschr (1974) 0.80
[Anatomical and radiological study of knee-joint involvement in a case of ochronosis]. Schweiz Med Wochenschr (1971) 0.80
Letter: HL-A 27 in diagnosis of rheumatic diseases. Lancet (1974) 0.79
Molecular analysis of HLA-DR polymorphism in polymyalgia rheumatica. Swiss Group for Research on HLA in Polymyalgia Rheumatica. J Rheumatol (1997) 0.79
OM-8980 in rheumatoid arthritis: a 6-month double blind placebo controlled multicenter study. J Rheumatol (1989) 0.79
Immunomodulation by alpha 2-macroglobulin and alpha 2-macroglobulin-proteinase complexes: the effect on the human T lymphocyte response. Eur J Immunol (1988) 0.79
Migration inhibition factor-like activity in inflammatory synovial fluids might be due to proteases. Clin Exp Immunol (1976) 0.79
[Destructive arthropathies associated with articular chondrocalcinosis. Clinical and metabolic study of 16 cases]. Schweiz Med Wochenschr (1976) 0.79
Suramin stimulates B-lymphocyte proliferation in the mouse. Agents Actions (1976) 0.78
Male sex predominance in Chlamydia trachomatis sexually acquired reactive arthritis: are women more protected by anti-chlamydia antibodies? Ann Rheum Dis (2001) 0.78
Lymphocytotoxic antibodies in rheumatoid arthritis: relation to HLA-DR2 and rheumatoid factors. Clin Exp Rheumatol (1986) 0.78
Activation of resting T lymphocytes by cross-linked anti-CD3 (T3). Eur J Immunol (1987) 0.78
Human alpha 2-macroglobulin as an inhibitor of insoluble trypsin. Biochem Biophys Res Commun (1989) 0.78
Protease inhibitors reduce mitogen induced lymphocyte stimulation. Immunology (1979) 0.78
Quantitative determination of antiglobulins of the IgG, IgA, and IgM class in sera of patients with rheumatoid arthritis or chronic liver disease and of healthy persons. Rev Eur Etud Clin Biol (1972) 0.77
alpha 2M-proteinase complexes are taken up by macrophages during joint inflammation. Adv Exp Med Biol (1982) 0.77
Association between human parvovirus B19 infection and arthritis. Ann Rheum Dis (1995) 0.77
Different humoral immune response to Chlamydia trachomatis major outer membrane protein variable domains I and IV in Chlamydia-infected patients with or without reactive arthritis. Arthritis Rheum (1999) 0.76
A study of the incidence of articular chondrocalcinosis in Paget's disease of bone. Scand J Rheumatol (1976) 0.76
Diet and fatty acids: can fish substitute for fish oil? Clin Exp Rheumatol (1991) 0.76
Synovial deposit of osmic acid after intra-articular injection. Anatomical and radiologic study of a case. Virchows Arch A Pathol Anat Histol (1976) 0.76
Synovial fluid hydroxyapatite crystals: detection thresholds of two methods. Ann Rheum Dis (1989) 0.76
To assess the effect of slow-acting anti-rheumatic drugs in man. Agents Actions Suppl (1979) 0.76
Pyrophosphate arthropathy in the carpal and metacarpophalangeal joints. Ann Rheum Dis (1983) 0.75
Neutral proteinases induce rheumatoid factor production in mouse spleen cell cultures. Clin Exp Immunol (1984) 0.75
Adult seronegative arthritis with antinuclear antibodies: a distinct group of patients with a different immunogenetic pattern from seropositive rheumatoid arthritis and a good outcome. Rev Rhum Engl Ed (1996) 0.75
Clinical response to therapy with thymopoietin pentapeptide (TP-5) in rheumatoid arthritis. Ann Rheum Dis (1982) 0.75
HLA-DR4 does not predispose to higher amounts of rheumatoid factors in healthy persons. Ann Rheum Dis (1983) 0.75
[Arthropathy due to hemochromatosis: often inaugural manifestation of the disease]. Schweiz Med Wochenschr (1992) 0.75
[Chlamydia infections in rheumatology]. Rev Rhum Ed Fr (1994) 0.75
[Current approach to low back pain]. Schweiz Med Wochenschr (1997) 0.75
[Rheumatic disorders and AIDS]. Ther Umsch (1989) 0.75
Homologous disease, a model for autoimmune disease. Ann N Y Acad Sci (1965) 0.75
Conservative inhospital management of low back pain patients. Factors predicting two-year outcomes. Rev Rhum Engl Ed (1998) 0.75
Medical approach to low back pain. Baillieres Clin Rheumatol (1992) 0.75
Production of neutrophil activating peptide-1 (NAP-1/IL-8) by blood and synovial fluid mononuclear cells from patients with arthritis. Clin Exp Rheumatol (1992) 0.75
Role of physical therapy in the management of common low back pain. Baillieres Clin Rheumatol (1992) 0.75
Palindromic syndrome: appearance of chondrocalcinosis after 47 years of evolution. J Rheumatol (1993) 0.75
[Rheumatologic complications in patients treated with intermittent hemodialysis]. Schweiz Rundsch Med Prax (1989) 0.75